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Abstract
Background and Purpose—Penumbral biomarkers promise to individualize treatment 
windows in acute ischemic stroke. We used a novel MRI approach which measures oxygen 
metabolic index (OMI), a parameter closely related to PET-derived cerebral metabolic rate of 
oxygen utilization, to derive a pair of ischemic thresholds: (1) an irreversible-injury threshold 
which differentiates ischemic core from penumbra and (2) a reversible-injury threshold which 
differentiates penumbra from tissue not-at-risk for infarction.
Methods—Forty acute ischemic stroke patients underwent MRI at three time-points after stroke 
onset: < 4.5 hours (for OMI threshold derivation), 6 hours (to determine reperfusion status), and 1 
month (for infarct probability determination). A dynamic susceptibility contrast method measured 
CBF, and an asymmetric spin echo sequence measured OEF, to derive OMI (OMI=CBF*OEF). 
Putative ischemic threshold pairs were iteratively tested using a computation-intensive method to 
derive infarct probabilities in three tissue groups defined by the thresholds (core, penumbra, and 
not-at-risk tissue). An optimal threshold pair was chosen based on its ability to predict: infarction 
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in the core, reperfusion-dependent survival in the penumbra, and survival in not-at-risk tissue. The 
predictive abilities of the thresholds were then tested within the same cohort using a 10-fold cross-
validation method.
Results—The optimal OMI ischemic thresholds were found to be 0.28 and 0.42 of normal values 
in the contralateral hemisphere. Using the 10-fold cross-validation method, median infarct 
probabilities were 90.6% for core, 89.7% for non-reperfused penumbra, 9.95% for reperfused 
penumbra, and 6.28% for not-at-risk tissue.
Conclusions—OMI thresholds, derived using voxel-based, reperfusion-dependent infarct 
probabilities, delineated the ischemic penumbra with high predictive ability. These thresholds will 
require confirmation in an independent patient sample.
Background and Purpose
Imaging the ischemic penumbra during hyperacute stroke has been actively investigated 
because of its potential to individualize therapeutic opportunities beyond population-defined 
time-windows. The ischemic penumbra was defined by Astrup1 as “a zone of 
nonfunctioning but viable tissue that may recover its function if blood flow can be restored, 
for example, by therapeutic intervention.” This concept originated from electrophysiological 
studies in primates which revealed two cerebral blood flow (CBF) thresholds: a lower 
threshold of ion-pump failure that was associated with tissue infarction, and an upper 
threshold denoted by electrical failure, but associated with preserved tissue structure. The 
initial use of CBF thresholds to define the penumbra was problematic because the threshold 
delineating the ischemic core changed with increasing duration of ischemia.2 Subsequent 
PET studies in animal models and in stroke patients demonstrated that as CBF dropped in 
the affected region, oxygen extraction fraction (OEF) increased in attempt to maintain 
tissue-level metabolism or cerebral metabolic rate of oxygen utilization (CMRO2 = CBF × 
OEF × arterial oxygen content). Despite elevation of OEF in the peri-infarct region, OEF 
alone was found to be a relatively weak predictor of tissue outcome,3 whereas CMRO2 more 
consistently delineated tissue that eventually died4–6 with thresholds for infarction ranging 
from 0.87–1.7 mL 100g−1 min−1 CMRO2< 23–55% of normal values. Values at the lower 
end of the range were derived from single voxel measurements of both gray and white 
matter, whereas those at the higher end were determined from larger regions of interest 
primarily in gray matter.4, 7–11 Unlike CBF thresholds, CMRO2 thresholds appeared 
independent of the time interval after stroke onset, making it ideal for imaging salvageable 
tissue in stroke patients who present at various times after stroke onset.12
Given the logistical hurdles of PET in hyperacute stroke patients, MR and CT methods have 
been actively explored. While initial studies of MR diffusion perfusion mismatch (DPM) 
and CT perfusion mismatch as a penumbral imaging signature were promising, clinical trials 
were unable to demonstrate improved clinical outcomes when selecting patients with DPM 
for therapy. The Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) 
randomized patients to tPA vs. placebo between 3–6 hours from stroke onset.13 Patients 
with DPM who were given tPA did not show significantly decreased infarct growth 
compared to placebo. The Desmoteplase in Acute Stroke (DIAS) -II trial did not 
demonstrate any benefit with a novel thrombolytic, desmoteplase, compared to placebo in 
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mismatch-selected patients.14 MR RESCUE (Mechanical Retrieval and Recanalization of 
Stroke Clots Using Embolectomy) randomized patients to clot retrieval vs. medical therapy 
within 8 hours of onset and found no benefit from intervention in patients with penumbral 
pattern using mismatch criteria.15 Further DPM trials are underway, to determine if 
optimized DPM thresholds will identify individuals who might benefit from acute 
interventions.
With the goal of finding a physiological biomarker of penumbral tissue, we developed an 
MR method capable of assessing cerebral oxygen metabolism termed MR-oxygen metabolic 
index (OMI).16 This method has been validated in animal models subjected to hypoxia, 
hypercapnia, and middle cerebral artery occlusion against jugular venous oxygen saturation 
sampling.17 In healthy subjects inhaling variable mixtures of carbogen, OMI yielded similar 
values to those found in PET studies with high reproducibility.18 Furthermore, in a study of 
acute stroke patients, OMI values in the eventually infarcted region were 0.40 ± 0.24 of the 
contralateral hemisphere, consistent with PET-derived CMRO2 values for non-viable 
tissue.8
In this prospective imaging study, we tested OMI as a predictor of tissue fate in a cohort of 
acute ischemic stroke patients imaged within 4.5 hours of stroke symptom onset and re-
imaged at 6 hours after stroke onset to assess reperfusion status. Using a voxel-by-voxel 
approach, our aim was to derive two quantitative ischemic thresholds for delineation of the 
ischemic penumbra: (1) a lower threshold of irreversible injury which differentiated 
ischemic core from penumbra and (2) an upper threshold of reversible injury which 
differentiated penumbra from oligemia. Consistent with Astrup’s definition,1 penumbra was 
defined based on reperfusion-dependent tissue survival: if reperfused, penumbral tissue 
should survive; if not reperfused, penumbral tissue should die.
Methods
Patients and Inclusion Criteria
Approval of the protocol was obtained from the Washington University Human Studies 
Committee. This was a prospective, observational MRI study in acute ischemic stroke 
patients at a large, urban, tertiary care referral center. There was no overlap of patients 
between the current study and previous reports of OMI. After providing written informed 
consent, both intravenous (IV) tPA-treated and untreated acute ischemic stroke patients with 
a National Institutes of Health Stroke Scale (NIHSS) ≥ 5 were enrolled (Supplementary 
Online Table for full inclusion and exclusion criteria). The study imposed no delay in time-
to-tPA treatment and no deviation from standard monitoring practices. The NIHSS was 
collected prospectively by a stroke neurologist or stroke research coordinator on admission, 
at 72 hours, and at all imaging time points. Clinical data including demographic data and 
past medical history were obtained by the research coordinator prospectively at the time of 
patient enrollment.
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Magnetic Resonance Imaging Protocol
Patients underwent serial MRI scans at three time-points (tp): within 4.5 hours (tp1), at 6 
hours (tp2), and at 1 month (tp3) after stroke onset, on a 3T Siemens whole body Trio. For 
patients receiving IV tPA, the tp1 scan was performed as soon as possible after tPA bolus 
(during tPA infusion). Six hours was chosen for the time of reperfusion measurement 
because reperfusion-based therapies administered within, but not beyond, this time-frame 
have demonstrated clinical efficacy.19, 20 One month was chosen as the time for final infarct 
determination as stroke-related edema has diminished significantly by one month and 
atrophy may become significant beyond one month.21, 22
The protocol included diffusion-weighted, FLAIR [TR/TE=10000/115 ms; inversion time = 
2500 ms; matrix=512×416; 20 slices, slice thickness (TH)=5mm], MPRAGE, and dynamic 
susceptibility contrast (DSC) perfusion images with 0.2ml/kg gadolinium contrast injected at 
5 ml/sec (a T2*-weighted gradient echo EPI sequence; TR/TE=1500/43ms; 14 slices, 
TH=5mm, zero interslice gap; matrix=128×128). The protocol did not include magnetic 
resonance angiography (MRA). The DSC method provided the perfusion weighted imaging 
(PWI) for calculation of CBF and cerebral blood volume (CBV) maps. Mean transit time 
(MTT) was calculated as CBV/CBF. Voxels within the proximal middle cerebral artery 
(MCA) of the contralateral hemisphere were manually chosen and the mean concentration 
curve of these voxels was used as the arterial input function (AIF). A time-shift insensitive 
block-circulant singular value decomposition method was utilized to minimize effects of 
time lag of the AIF on perfusion measurements.23 To minimize large vessel effects which 
contribute to artifactually high signal near the cortical vertices, voxels with CBV > 10% of 
were removed and excluded from further analysis in deriving OMI thresholds for core, 
penumbra, and not-at-risk tissues (normal CBV for gray matter is 3–5% and for white matter 
is 1.5–3%). An asymmetric spin echo sequence was used to calculate OEF.24 Oxygen 
metabolic index (OMI) was calculated as CBF × OEF. Measurements were normalized to 
the contralateral unaffected hemisphere. Detailed descriptions for quantification of OEF and 
OMI can be found elsewhere.24, 25 MR-OEF images were acquired in 30 second epochs, so 
that those with significant motion artifact could be removed from the final signal-averaged 
OEF measure. If more than 10% of OEF images from a single time-point were removed due 
to motion, the patient was removed from the analysis.
Six parameter rigid image registration was performed to align all images across tp1, tp2, and 
tp3 for each patient using a well-established linear registration tool FSL 3.2 (FMRIB, 
Oxford, UK).26 Accuracy of image registration was evaluated manually by a board-certified 
neuroradiologist (K.D.V.) who checked several structural landmarks, such as the ventricle 
and brain boundaries, in all registered images and their corresponding template image for 
each patient. If co-registration was found to be discrepant from the template image of more 
than 3 voxels in any direction, the registration algorithm was modified and rerun to improve 
alignment. Using this manual checking process, no patients who had all three imaging time-
points were removed due to inadequate co-registration.
Tissue segmentation into gray and white matter, necessary for calculation of CBF and OMI 
prior to normalization with the contralateral hemisphere, was performed using a semi-
automated approach using FSL 3.2 (FMRIB, Oxford, UK) for automatic segmentation26 
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followed by manual correction by a board-certified neuroradiologist (M.R.P.) using SNAP-
ITK 2.2.0.27 For delineation of the final infarct, hyperintense lesions were manually outlined 
on the 1 month FLAIR image by a board-certified vascular neurologist (A.L.F.) who was 
blinded to the OMI data. Each voxel on the 1 month FLAIR image was assigned a value of 
“dead” or “alive” for infarct probability analysis.
Derivation of OMI Thresholds
All tp1 OMI voxels within the affected hemisphere were included for OMI threshold 
evaluation. Two OMI thresholds for delineating the ischemic penumbra were derived from 
the individual patient tp1 OMI maps based on a computation-intensive approach searching 
for the optimal threshold pair, which included: (1) a lower irreversible injury OMI threshold 
to distinguish the ischemic core from the ischemic penumbra and (2) an upper reversible 
injury OMI threshold to distinguish ischemic penumbra from tissue ‘not-at-risk’ for 
infarction. Specifically, a four-cell approach, reflecting four different tissue categories (core, 
non-reperfused penumbra, reperfused penumbra, and not-as-risk tissue) was employed. OMI 
threshold pairs were iteratively tested, searching for the threshold pair which resulted in 
infarct probabilities (IP) closest to ideal values in each tissue group of interest: (1) core 
(tissue died regardless of reperfusion), ideal IP=100%; (2) non-reperfused_penumbra (tissue 
died without reperfusion), ideal IP=100%; (3) reperfused_penumbra (tissue survived with 
reperfusion), ideal IP=0%; and (4) not-as-risk tissue (tissue survived regardless of 
reperfusion), ideal IP=0% (Figure 1). To this end, the threshold pair with the lowest 
“average prediction error (APE)”, a metric averaging the differences for each tissue group’s 
actual infarct probability from the ideal, was selected as optimal pair for delineating the 
penumbra. Therefore, APE = (|100% − IPcore|+| 100% − IPnon-reperfused_penumbra|+|0% − 
IPreperfused_penumbra|+|0% − IPnot-at-risk|) / 4. Threshold pairs were derived in individual 
patients and the median infarct probabilities and corresponding average prediction error 
were calculated for each pair. The pair with the lowest median average prediction error 
across the total sample was chosen as optimal. Hypoperfusion was defined in regions with 
MTT prolongation beyond the median MTT of the contralateral hemisphere (MTTp) > 4 
seconds at tp1. “Reperfusion” within the penumbra was defined as MTTp < 4 seconds at tp2 
based on our previous analyses evaluating MTTp thresholds.28 “Non-reperfusion” was 
defined as a voxel with an MTTp perfusion deficit > 4 seconds at tp2. OMI threshold ranges 
(0.16–0.32 for irreversible-injury and 0.38–0.52 for reversible-injury in increments of 0.02) 
were chosen based on threshold ranges found within PET literature measuring CMRO2 in 
ischemic stroke patients.29 To reduce noise-induced effects, a minimum volume of 1 ml for 
a tissue group was required to be included for average prediction error calculation.
Cross-validation of OMI Thresholds
The predictive abilities of the derived OMI thresholds were tested in the same sample using 
a 10-fold cross-validation method.30 The sample was partitioned into 10 equal subsamples. 
Of the 10 subsamples, 9 subsamples were used to derive the optimal ischemic thresholds. 
The derived thresholds were then tested on each of the patients within the one subsample 
left-out; average prediction error and the infarct probabilities for the tissue groups were 
calculated. This cross-validation process was repeated nine times, with each of the 10 
subsamples used only once as the test subsample. Population-level infarct probabilities and 
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average prediction errors were displayed as median [25th quartile, 75th quartile]. Analyses 
were performed using Matlab v. R2012a.
Results
Sixty-four patients who met all inclusion and exclusion criteria were consented and 
underwent tp1 imaging, of whom 24 patients were excluded due to: (1) inability to get tp2 
due to medical instability, intolerance of tp1 MRI due to claustrophobia, or early reperfusion 
on tp1 imaging (N=7); (2) lost to follow-up or died prior to last imaging session (N=10); or 
(3) poor data quality due to motion artifact (N=7) (Supplemental Online Figure). Therefore, 
40 patients were included in the final analysis. Baseline clinical and imaging characteristics 
for the 40 patients are shown in Table 1. These patients were imaged at a median of 2.7 hr 
(tp1), 6.3 hr (tp2), and 1 month (tp3) after stroke onset.
Deriving the optimal OMI thresholds for delineating the penumbra
Putative OMI threshold pairs were used to define 3 tissue groups: core, penumbra, and not-
at-risk. The putative penumbra was further subdivided by reperfusion status (non-reperfused 
penumbra and reperfused penumbra). Infarct probabilities were determined for each of these 
four tissue groups: core, non-reperfused penumbra, reperfused penumbra, and not-at-risk. 
Figure 2 shows an example from one patient, using the OMI threshold pair, 0.28 for 
irreversible injury and 0.42 for reversible injury. Infarct probabilities for this patient were 
98.0% for core, 68.3% for non-reperfused penumbra, 9.8% for reperfused penumbra, and 
1.1% for not-at-risk, yielding an “average prediction error” of 11.2%. The “average 
prediction error” is a value which describes the average deviation from ideal infarct 
probabilities (see Methods).
Using a computation-intensive search method, all possible threshold pairs within pre-defined 
ranges were applied to all patients, and infarct probabilities were calculated for each of the 
tissue groups. A median population average prediction error was calculated for each 
threshold pair. A matrix of threshold pairs with its corresponding median average prediction 
error values was created and displayed as a 3-D graph (Figure 3). The ideal threshold pair 
was defined as the pair with the lowest average prediction error value, indicating the lowest 
deviation from ideal prediction of tissue outcome. A single threshold pair was found to have 
the lowest average prediction error from the patient population, corresponding to an OMI 
threshold of 0.28 for irreversible injury and 0.42 for reversible injury (Figure 3, *). This 
optimal threshold pair yielded an average prediction error of 8.75%, corresponding to the 
following infarct probabilities: (1) 92.9% [61.5, 97.6] for core, 92.2% [77.3, 96.4] for non-
reperfused penumbra, 9.95% [0.30, 28.5] for reperfused penumbra, and 6.28% [1.72, 14.0] 
for not-at-risk tissue.
Testing the predictive ability of OMI thresholds
The 10-fold cross-validation method produced thresholds ranging from 0.24–0.28 for the 
irreversible injury threshold and from 0.42–0.44 for the reversible injury threshold for the 10 
subsample derivation sets. The 10 subsample threshold data is shown in Table 2. The 
median infarct probabilities in the 10 subsample test sets were: 90.6% [61.5, 97.7] for core, 
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89.7% [78.0, 95.2] for non-reperfused penumbra, 9.95% [0.33, 28.2] for reperfused 
penumbra, and 6.28% [1.72, 14.0] for not-at-risk tissue, corresponding to an average 
prediction error of 11.4% [2.69, 21.0] (Table 3).
Discussion
In this prospective imaging study, a novel MR parameter designed to measure cerebral 
oxygen metabolism (OMI) was tested to determine if it could accurately delineate the 
ischemic penumbra. Two optimal OMI thresholds were identified which delineated core, 
penumbra, and oligemic tissue, and yielded reperfusion-dependent infarct probabilities close 
to ideal predicted tissue fate. Penumbral infarct probabilities within each voxel of tissue 
were strictly defined by reperfusion status: the ideal infarct probability was 0% if reperfused 
and 100% if not reperfused. Moreover, when the optimal thresholds were tested using the 
cross-validation technique, thresholds demonstrated little variability and yielded median 
infarct probabilities that were near ideal, suggesting that the derived thresholds were highly 
predictive of ideal tissue fate across the population.
The current study has several strengths: (1) our definition of penumbra was based on the 
definition by Astrup,1 as operationalized by others,5 requiring that reperfused voxels 
between the two optimal thresholds have low infarct probability and non-reperfused voxels 
have high infarct probability; (2) the timing of reperfusion measurement at six hours was 
chosen specifically to be within a time window known to impact clinical outcome in 
previous stroke populations;19, 31 we aimed to define the OMI thresholds based on 
clinically-relevant reperfusion that would truly salvage tissue;28 (3) we used a novel, 
unbiased approach to derive ischemic thresholds by employing a computation-intensive 
search method to minimize average prediction error; and (4) a voxel-wise approach was 
utilized for all analyses: all definitions were applied to co-registered voxels at three time-
points, rather than visual, regional, or volumetric analyses.13, 14, 32
In the current study, we derived OMI thresholds for a time window in which reperfusion-
promoting therapies are known to improve outcomes; however, future studies will test these 
thresholds at later windows. PET data suggests the CMRO2 threshold delineating tissue 
outcome may be independent of time from symptom onset.12, 29 This theory of time-
independence is based on independent studies which have measured CMRO2 at different 
time-points and arrived at a similar threshold for delineating tissue with eventual infarction; 
however, this threshold has not been tested for time-independence within a single study. 
Therefore, it will be important to determine if the OMI thresholds derived in this study will 
predict reperfusion-based tissue fate at later time windows.
A challenge with clinical trials thus far has been defining penumbral thresholds, which have 
largely been chosen empirically.13, 14, 33 In early DPM trials, the reversible injury threshold 
(using a PWI-based parameter to separate penumbra from oligemia) was found to 
encompass significant oligemic tissue that was not at true risk for eventual infarction.13, 33 
Post-hoc analyses helped to refine the optimal thresholds for use in subsequent 
studies.15, 34–36 More recently, MR-RESCUE investigators rigorously derived the threshold 
for irreversibly-injury by developing a multi-parametric model (including DWI and PWI 
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parameters) to predict the infarct core in the setting of successful recanalization.37 The 
threshold for reversible injury was not optimized, but was empirically chosen. To build upon 
these methods, we aimed to prospectively identify the best-performing, quantitative 
penumbral thresholds for both irreversible and reversible injury so that the optimal 
thresholds would be known if tested within the context of a clinical trial.
This study has several limitations. 1) Data was obtained from a single institution; therefore, 
the generalizability of thresholds to other populations is unknown. 2) Inclusion criteria 
required NIHSS ≥ 5; therefore, this cohort captured strokes of greater severity (median 
NIHSS=14) than average stroke patients. 3) Because the first imaging session occurred, on 
average, 46 minutes after tPA treatment, some tissue that was initially ischemic might have 
been lost to analysis due to early reperfusion. 4) Tissue (gray-white matter) segmentation is 
required for calculating normalized OMI. Therefore, prior to implementation in clinical 
practice, a rapid processing algorithm will need to be developed, similar to current rapid 
post-processing tools used for diffusion-perfusion mismatch.38 5) We assessed the 
reproducibility and predictive ability of the OMI thresholds on the same patient cohort in 
which the thresholds were derived using a statistical resampling method. Therefore, the 
thresholds will need to be tested in an independent population. 6) The clinical utility of OMI 
ischemic thresholds will need to be tested to evaluate how much OMI-defined penumbral 
tissue is required to yield meaningful clinical benefit and whether OMI promotes the 
efficacy of an intervention by appropriately selecting patients for therapy. 7) Finally, we are 
directly comparing MR-OMI values to PET derived CMRO2 values in patients with 
cerebrovascular disease in an ongoing study, which will permit further refinement of MR-
OMI.
Conclusion
OMI ischemic thresholds, derived using voxel-based final infarct and reperfusion status, 
delineated the ischemic penumbra with high predictive ability and were consistent when 
retested within the population. These thresholds will require further testing in independent 
patient cohorts.
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Figure 1. Deriving OMI Penumbral Thresholds
§Irreversible-injury and reversible-injury OMI threshold pairs separated the tissue within the 
ischemic hemisphere into core, penumbra, and not-at-risk; penumbra was further subdivided 
by reperfusion status (non-reperfused penumbra and reperfused penumbra). For each pair, 
the infarct probability (IP) from each tissue group was calculated. A computation-intensive 
search method was performed to find the OMI threshold pair that corresponded to the lowest 
average prediction error (a metric averaging the differences of the actual infarct probabilities 
from ideal infarct probabilities for all tissue groups). Average prediction error (APE) = {|
100%−IPcore|+|100%−IPnonreperfused_penumbra|+|0%−IPreperfused_penumbra|+|0%
−IPnot-at-risk|}/4; Ideal APE=0%. Pairs of irreversible and reversible-injury thresholds were 
iteratively tested and infarct probabilities in each of the four tissue groups and the 
corresponding average prediction error were calculated. The threshold pair with the lowest 
average prediction error was selected as the pair of optimal OMI thresholds.
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Figure 2. Patient Example
A 27 year old man with a right middle cerebral artery stroke (NIHSS=16) underwent tp1 
MRI at 2:10 after symptom onset (during tPA infusion) followed by tp2 MRI at 6:28 after 
onset. Using tp1 OMI map (Column A), an example OMI threshold pair (core/
penumbra=0.28, penumbra/not-at-risk=0.42) divided the tissue into predicted core, 
penumbra, and not-at-risk; penumbra was further subdivided based on reperfusion status 
(determined by tp2 scan) (Column B). For each of the four tissue groups (C), tissue that died 
(red) or survived (green) was determined based on the infarct delineated on FLAIR imaging 
at 1 month (Column D). The actual infarct probabilities from each group were calculated 
and subtracted from the ideal infarct probabilities, from which the average prediction error 
for this threshold pair in this patient was calculated.
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Figure 3. Population-derived Average Prediction Errors as a function of varying the OMI Core/
Penumbra and Penumbra/Not-at-Risk Threshold Pairs
A 3-D matrix of OMI threshold pairs with the corresponding median average prediction 
error values was plotted. The irreversible injury OMI threshold is on the x-axis. The 
reversible injury OMI threshold is on the y-axis. The average prediction error (APE) is on 
the color scale (in-plane) axis with cool colors representing the lowest average prediction 
error (closest to ideal) and warm colors representing the highest average prediction error 
(farthest from ideal). The ideal threshold pair was defined as the pair with the lowest 
average prediction error value, indicating the lowest deviation from ideal tissue outcome. 
The lowest single minimum average prediction error (8.75%) is found at the dark-blue 
square (*) corresponding to an irreversible injury threshold of 0.28 and a reversible injury 
threshold of 0.42.
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Table 1
Patient Characteristics (N=40)
Female, n (%) 14 (35%)
Age (years) 64 [57, 72]
Admission NIHSS 14 [8, 19]
African-American, n (%) 14 (35%)
tPA treatment, n (%) 30 (75%)
Admission Mean Arterial Pressure (mmHg) 114 [106, 128]
Admission Glucose (mg/dl) 126 [107, 149]
Time to tp1, hour 2.7 [2.1, 3.5]
Time to tp2, hour 6.3 [6.1, 6.5]
History of Hypertension, n (%) 31 (78%)
History of Diabetes, n (%) 11 (28%)
History of Congestive Heart Failure, n (%) 5 (12%)
Current Tobacco Use, n (%) 12 (30%)
History of Coronary Artery Disease, n (%) 12 (30%)
History of Stroke or TIA, n (%) 8 (20%)
Continuous data shown as median [interquartile range]; NIHSS = National Institutes of Health Stroke Scale; tp1=time-point 1 MRI; tp2=time-point 
2 MRI; TIA=transient ischemic attack
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Table 2
Cross-validation Results for the Optimal OMI Thresholds in the 10 Subsamples
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Table 3
OMI Threshold 10-Fold Cross-Validation: Population-derived Median Infarct Probabilities and Average 
Prediction Error





Reperfusion 9.95% [0.33, 28.2]
APE† = 11.4% [2.69, 21.0]
IP=Infarct Probability; Data shown as Median [25th quartile, 75th quartile].
†
APE (Average Prediction Error) = (|100% − IPcore|+|100% − IPnon-reperfused_penumbra|+|0%−IPreperfused_penumbra|+|0%
−IPnot-at-risk|) / 4; Ideal APE = 0%.
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